Kazimierz Węglarczyk

Author

Also Known As

K WEGLARCZYK, K Weglarczyk, K Węglarczyk, K. Weglarczyk, K. Węglarczyk, KAZIMIERZ WĘGLARCZYK, Kazimierz Weglarczyk, Kazimierz Węglarczyk

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Jagiellonian University Polish Academy of Sciences Centre National de la Recherche Scientifique Maj Institute of Pharmacology Inserm

About

Kazimierz Węglarczyk is an author at Jagiellonian University specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.2K
2	Health Sciences	1	1	71
3	Allergy	1	1	66
4	Biochemistry	1	1	14
5	Biomedical Engineering	1	1	71

Kazimierz Węglarczyk

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes Monika Baj‐Krzyworzeka, Rafał Szatanek, Kazimierz Węglarczyk, Cancer Immunology Immunotherapy Several Surface DeterminantsTumour-derived MicrovesiclesBiological MicroenvironmentsTumour CellsCell-matrix Interaction	2005	385
Circulating tumour-derived microvesicles in plasma of gastric cancer patients Jarosław Baran, Monika Baj‐Krzyworzeka, Kazimierz Węglarczyk, Cancer Immunology Immunotherapy Gastrointestinal OncologyMedicineGastric Cancer PatientsPathologyOncology	2009	257
Interplay Between Heme Oxygenase-1 and miR-378 Affects Non-Small Cell Lung Carcinoma Growth, Vascularization, and Metastasis Klaudia Skrzypek, Magdalena Tertil, Maciej Cieśla, Antioxidants and Redox Signaling	2013	144
Tumour-derived microvesicles modulate biological activity of human monocytes Monika Baj‐Krzyworzeka, Rafał Szatanek, Kazimierz Węglarczyk, Immunology Letters Tumour-derived MicrovesiclesBiological MicroenvironmentsExtracellular MicrovesiclesMedicineCell Biology	2007	124
Immune cells lacking Y chromosome show dysregulation of autosomal gene expression Jan P. Dumanski, Jonatan Halvardson, Hanna Davies, Cellular and Molecular Life Sciences	2021	99
Antitumor response of CD14+/CD16+ monocyte subpopulation Anna Szaflarska, Monika Baj‐Krzyworzeka, Maciej Siedlar, Experimental Hematology Antitumor ResponseCancer ImmunosurveillanceImmunologyImmunotherapyMedicine	2004	98
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein–Protein Interaction Damian Muszak, Ewa Surmiak, Jacek Plewka, Journal of Medicinal Chemistry	2021	86
A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection Krzysztof Klimkiewicz, Kazimierz Węglarczyk, Guillaume Collet, Cancer Letters Biological MicroenvironmentsHypoxia EffectsMelanoma GrowthBiomedical EngineeringCancer Biology	2017	71
Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients Maciej Siedlar, Magdalena Strach, Karolina Bukowska-Straková, Clinical Immunology Primary ImmunodeficiencyInflammationAutoimmune DiseaseAllergyImmunodeficiencies	2011	66
Fas (CD95)-Fas Ligand Interactions Are Responsible for Monocyte Apoptosis Occurring as a Result of Phagocytosis and Killing of<i>Staphylococcus aureus</i> Jarosław Baran, Kazimierz Węglarczyk, M. Mysiak, Infection and Immunity	2001	64

Page 1